Michigan Institute for Clinical and Health Research (MICHR)

密歇根临床与健康研究所 (MICHR)

• 批准号: 10570320
• 负责人: Julie C Lumeng
• 金额: $ 630.91万
• 依托单位: UNIVERSITY OF MICHIGAN AT ANN ARBOR
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-07-01 至 2023-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10570320
• 关键词: Clinical; Clinical Research; Communities; Health; Health Policy; Informatics; Institutes; Longevity; Michigan; Phase; Process; Research; Research Methodology; Research Personnel; Science; Societies; Translational Research; Translations; Universities; Work; clinical care; community partnership; innovation

Project Summary The Michigan Institute for Clinical & Health Research (MICHR) is a catalytic hub that significantly impacts the translation of investigative science into innovative improvements in clinical care and health policy. During this extension period, we will continue to empower researchers and research communities within and outside the University of Michigan (U-M), positively impacting health across local, regional, national, and global scales. MICHR will achieve this positive impact by continuing our work through the previously established overarching specific aims: 1) Innovate and implement effective educational approaches to developing a skilled and diverse translational research workforce; 2) Catalyze effective research with community partnerships to accelerate the translation of breakthroughs that benefit society; 3) Promote clinical and translational research across translational phases and across the lifespan; 4) Advance research methods and processes that enable higher quality clinical and translational research; 5) Develop, demonstrate, and disseminate informatics innovations that facilitate the translation of biomedical discoveries to health impact. We anticipate an expanded positive impact during this extension period as we demonstrate and disseminate our innovations across the U-M campus, surrounding communities, and the CTSA consortium.

项目摘要 密歇根州临床与健康研究所（MICHR）是一个催化中心， 将调查科学转化为临床护理和卫生政策的创新改进。在此 在延长期内，我们将继续授权研究人员和研究社区内外， 密歇根大学（U-M），在地方，区域，国家和全球范围内积极影响健康。 人权专员办事处将继续通过先前建立的总体框架开展工作， 具体目标：1）创新和实施有效的教育方法，以培养一个熟练的和多样化的 转化研究队伍; 2）与社区合作伙伴一起催化有效的研究，以加速 3）促进临床和转化研究， 翻译阶段和整个生命周期; 4）先进的研究方法和过程，使更高的 高质量的临床和转化研究; 5）开发，展示和传播信息学创新 促进将生物医学发现转化为健康影响。我们预计， 在此延长期内的影响，因为我们展示和传播我们的创新整个密歇根大学 校园、周边社区和CTSA联盟。

项目成果

Individualized prediction of chronic kidney disease for the elderly in longevity areas in China: Machine learning approaches.

• DOI: 10.3389/fpubh.2022.998549
• 发表时间: 2022
• 期刊: FRONTIERS IN PUBLIC HEALTH
• 影响因子: 5.2
• 作者: Su, Dai;Zhang, Xingyu;He, Kevin;Chen, Yingchun;Wu, Nina
• 通讯作者: Wu, Nina

Development of a new pregnancy informational and decisional needs survey for women with physical disabilities.

• DOI: 10.1016/j.dhjo.2020.101056
• 发表时间: 2021-07
• 期刊: Disability and health journal
• 影响因子: 4.5
• 作者: Kalpakjian CZ;Haapala HJ;Ernst SD;Orians BR;Barber ML;Wiseman AL;Mulenga L;Bolde S;Rosenblum S;Jay GM
• 通讯作者: Jay GM

Strategies and foundations for scientific discovery in longitudinal studies of bipolar disorder.

• DOI: 10.1111/bdi.13198
• 发表时间: 2022-08
• 期刊: Bipolar disorders
• 影响因子: 5.4

ARF6 is a host factor for SARS-CoV-2 infection in vitro.

• DOI: 10.1099/jgv.0.001868
• 发表时间: 2023-06
• 期刊: JOURNAL OF GENERAL VIROLOGY
• 影响因子: 3.8
• 作者: Mirabelli, C.;Cunha, J. Bragazzi;Wotring, J. W.;Sherman, E. J.;El Saghir, J.;Harder, J.;Kretzler, M.;Sexton, J. Z.;Emmer, B. T.;Wobus, C. E.
• 通讯作者: Wobus, C. E.

Using Peer Support to Prevent Diabetes: Results of a Pragmatic RCT.

• DOI: 10.1016/j.amepre.2023.02.015
• 发表时间: 2023-03
• 期刊: American journal of preventive medicine
• 影响因子: 5.5
• 作者: M. Heisler;Wendy T. Dyer;Holly Finertie;Shelley Stoll;Deanne Wiley;Cassie D. Turner;Tali Sedgwick;J. Kullgren;C. Richardson;M. Hedderson;J. Schmittdiel